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Summary
Objective: To determine if screening family members of patients with acute bru-
cellosis will enhance the detection rate of brucellosis and also to determine the
relationship between symptoms and brucella serology.
Materials and methods: Family members from patients with acute brucellosis were
interviewed and serologically screened. All seropositive family members were clini-
cally and serologically followed for six months.
Results: Twenty-five acute brucellosis patients and their 178 family members were
enrolled from January 2001 to February 2002. Of the 178 family members, 40 (23%)
manifested various symptoms, 138 (77%) were asymptomatic, with an overall ser-
oprevalence rate of 34 (19%). The rate of seropositivity among the symptomatic
family members was 23 (58%) and for the asymptomatic was 11 (8%) (P < 0.001). The
majority of the symptomatic family members (13 (57%)) had a high Brucella titer in
comparison to one (9%) of the asymptomatic group (P < 0.001). Acute brucellosis was
diagnosed and treated in 18 (78%) of the symptomatic seropositive family members
and in four (36%), of the asymptomatic seropositive family members with an acute
brucellosis prevalence rate of 22 (12%). All family members with acute infection
recovered without sequelae; one patient relapsed (5%).* Corresponding author. Tel.: +966 1 2520088; fax: +966 1 2520437.
E-mail address: memish@ngha.med.sa (Z.A. Memish).
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Conclusion: Symptomatic family members are more likely to be seropositive with a
high titer in comparison to the asymptomatic members.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
Brucellosis is endemic in Saudi Arabia and other
parts of the world.1—7 Humans acquire the infection
through the consumption of products of infected
animals such as unpasteurized milk, cheese and raw
meat.
In Saudi Arabia, the incidence of the disease is
high, particularly in the Central Najed region,
around the city of Riyadh, an area where part of
the population has a nomadic heritage which per-
petuates the ingestion of fresh camel, goat and
sheep milk.7,8 In addition, direct contact with
infected animals, their secretions or their carcasses
could lead to infection through inhalation or acci-
dental skin and mucous membrane penetration.9,10
Therefore, veterinarians, farmers, abattoir and
laboratory workers are at increased risk of contract-
ing the infection.10—12
Other than the possibility of transmission through
blood transfusion and organ or bone marrow trans-
plantation, brucellosis is not readily transmitted
between human beings. Congenital brucellosis has
been reported but it is rare.13—15 A few reports have
shown an increased incidence of brucellosis among
family members of an infected person, due mainly
to exposure to the same source of infection rather
than human-to-human transmission.12,16—20 Thus,
any case diagnosed in such a family may be an
indication of a population at risk.
In endemic areas such as Saudi Arabia, with a
potentially high rate of exposure within the popula-
tion, one may assume that for each reported case of
brucellosis many infections go unrecognized. By
active screening for brucellosis in such settings,
more infected individuals will be identified earlier
on in the course of the disease. Early identification
with early initiation of therapy will reduce the
incidence of complications and relapse.
In the authors’ previous report a seroprevalence
rateof13%amongfamilymembersofacutebrucellosis
cases was found with the majority (74%) being symp-
tomatic. But symptoms in the seronegative group
were not evaluated. Therefore, it was not possible
to conclude that screening should be restricted to the
symptomatic group purely for cost effectiveness.21
The purpose of this study was to assess the sig-
nificance of the presence of particular symptoms
among family members in increasing the yield of
screening, and to follow the course of symptomaticand asymptomatic seropositive family members to
determine which would develop active disease.Materials and methods
Study population
The study was performed in King Abdulaziz Medical
City, a 750-bed tertiary care center located in
Riyadh, Saudi Arabia, which cares for the Saudi
Arabian National Guard soldiers, officers, employ-
ees and their dependents.
Throughout this segment of the Saudi Arabian
population, many families maintain herds. The con-
sumption of unpasteurized dairy products from
camels, sheep and goats is common, even though
routine vaccination against brucellosis is not admi-
nistered to these animals. All the index cases were
infected through ingestion of unpasteurized raw
milk and there were no work-related infections.
Definitions
Index cases: these were National Guard employees
or dependents diagnosed as having acute brucellosis
during the period from January 2001 to February
2002 and who agreed to enroll in this study.
Acute brucellosis: the diagnosis of acute brucel-
losis was based on the Centers for Disease Control
(CDC) definition which includes the presence of
clinical signs and symptoms with evidence of Bru-
cella spp invasion in positive culture or a four-fold or
greater increase in titer of1:80 using the Standard
Tube Agglutination Test (SAT) or a single high titer
against Brucella spp of 1:160.22
Family members: were defined as all individuals
living in the same household as the index case and
who agreed to be interviewed and tested.
Symptomatic seropositives: were defined as
family members with Brucella antibody titer of
1:160 and symptoms compatible with brucellosis.
Asymptomatic seropositives: were defined as
family members with Brucella antibody titer
1:160, without any clinical symptoms suggestive
of brucellosis.
All family members of the index case that agreed
to be enrolled in the study were interviewed for the
presence of any symptoms during the three months
prior to the diagnosis of the index case.
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investigator (SA) using predesigned forms before
taking a blood sample for serology. The symptoms
sought were fever, night sweats, arthralgia, arthri-
tis, headache, weight loss, muscle and bone pain.
Throughout the study period the interviewer was
blind to the serology result or any referral to the
Infectious Disease Clinic. If a family member of an
index case refused the interview or the screening
blood test, the index case was not included in the
study.
Family screening was carried out as part of the
Infection Prevention and Control Department’s
activities in preparation for setting a policy to con-
trol brucellosis. The importance of family screening
is due to the absence of ongoing animal disease
eradication and the high prevalence of the disease
in the Kingdom.
Patients who were not included in the study were
not followed by the Infection Prevention and Control
Department and were followed instead by the infec-
tious disease specialist.
SAT was carried out using Brucella abortus and
Brucella melitensis antigens (stained B. abortus
SS14 and B. melitensis SS15 suspensions, Murex
Diagnostic). A Brucella antibody titer of 1:160
was considered positive. Another investigator (BA)
reviewed all family members’ serology results,
referring all positive results (SAT 1:160) to the
Infectious Disease Clinic for further evaluation.
Treatment and follow-up
The infectious diseases specialist prescribed
treatment for the symptomatic and asympto-
matic seropositive family members and decided
whether additional testing was required. Adults
were generally treated with doxycycline (100 mg
twice daily) and rifampin (600—900 mg once daily)
while children were treated with rifampin
(10—20 mg/kg/day once daily) and trimetho-
prim-sulfamethoxazole (co-trimoxazole 10 mg/
kg/day once daily) for a total of six weeks. Clinical
follow-up and serology were carried out at two,
four and six months respectively for all seroposi-
tive groups.
Statistical analysis
The Statistical Package for Social Sciences (SPSS)
and Microsoft Excel were used for statistical ana-
lysis. We expressed continuous variables as the
mean  S.D. (Standard Deviation) with median,
using the X2 test to compare proportions. For
expected frequencies less than five in contin-
gency tables, Fisher’s Exact Test rather than
the X2 test was used. All statistical tests weretwo-tailed. All data were entered using Epi Info
Version 6.02.Results
Acute brucellosis was diagnosed in 29 patients dur-
ing the 13-month study period from January 2001 to
February 2002. Of these, 25 index cases and their
families agreed to enroll in this study. The families
were subsequently interviewed and serologically
screened. Four index cases and their families
refused either the interview or the screening.
Of the total 178 family members, 84 (47%) were
male and 94 (53%) female. The age distribution of
family members was three months to 80 years with
median age of 16.6 years. Forty (23%) manifested
various types of symptoms and 138 (77%) were
asymptomatic. Thirty-four (19%) were seropositive
with Brucella antibody titer of 1:160, and 144
(81%) were seronegative with Brucella titer of
1:80 (Figure 1).
Symptomatic family members
Of the 40 symptomatic family members, 23 (58%)
were seropositive and 17 (42%) were seronegative
(Figure 1). The most common symptoms experi-
enced were arthralgia 29 (73%), fever 12 (30%),
malaise seven (18%), backache six (15%), headache
five (12.5%) and arthritis two (5%). (Table 1).
Among the 23 (58%) symptomatic and seroposi-
tive family members, 12 (52%) were children 14
years of age. The titers ranged from 1:160 to
1:20480 and 13 (57%) had a high titer of >1:1280
(Table 2). Previous history of brucellosis was
reported in eight (35%) and of these, one family
member had a titer of 1:5120. The remaining seven
all had a titer of 1:320 or lower.
Blood culture was obtained in 17 (74%) of the
symptomatic seropositives and of these, eight (47%)
were positive for B. melitensis (Table 2).
Asymptomatic family members
Among the 138 (77%) asymptomatic family mem-
bers, only 11 (8%) were seropositive and 127 (92%)
were seronegative (Figure 1). The majority, seven
(64%), of the seropositives had a low titer of1:320,
three (27%) had a titer of 1:1280 and only one (9%)
had a titer of 1:5120 (Table 2). All four who had high
titer1:1280 were children and all were considered
as acute brucellosis and were treated. Six (55%) had
previous history of brucellosis and all had a titer of
1:320 (Table 2).
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Figure 1 Screening procedure and follow-up of family members of patients with acute brucellosis.Follow-up
During the follow-up period, 18 (78%) of the symp-
tomatic seropositives were considered as having
acute brucellosis and were treated either initially
or on follow-up if titers were rising (Table 2). In
contrast, only four (36%) of the asymptomatic ser-
opositives were considered as having acute brucel-
losis and received treatment (P < 0.05); three wereTable 1 The relationship between brucellosis serology and t
acute brucellosis.
Serostatus
Seropositive n = 34 (19%) Ser
Clinically
Symptomatic 23 (58) 17
Asymptomatic 11 (8) 127
Brucella symptoms*
Fever 9 (75) 3
Arthralgia 18 (62) 11
Malaise 4 (57) 3
Arthritis 1 (50) 1
Anorexia 3 (100) 0
Backache 4 (67) 2
Headache 3 (60) 2
Weight loss 3 (100) 0
* Some patients had more than one symptom.treated initially and all were children with titer of
1:1280. One, a 14-year-old, was treated six
months later, secondary to rising titer and develop-
ment of symptoms.
All patients were treated on an outpatient basis,
except two pediatric patients who required admis-
sion secondary to severe arthritis, and one patient
who required drainage and lavage of the hip joint.
Among all 22 (12%) family members with acutehe clinical symptoms in family members of patients with
P-value
onegative n = 144 (81%) Total 178
<0.001
(42) 40
(92) 138
(25) 12 <0.001
(38) 29 <0.001
(43) 7 <0.05
(50) 2 0.291
(0) 3 —
(33) 6 <0.01
(40) 5 <0.01
(0) 3 <0.01
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Table 2 The relationship between the clinical symptoms, SAT titers and treatment in seropositive family members.
Seropositives P-value*
Symptomatic 23 (58%) Asymptomatic 11 (8%)
SAT titer <0.05
1280 10 (50%) 10 (50%)
>1280 13 (93%) 1 (7%)
Previous history of brucellosis
Positive 8 (57%) 6 (43%)
Negative 15 (75%) 5 (25%)
Blood culture <0.05
Positive 8 (100%) 0 (0%)
Negative 9 (69%) 4 (31%)
Acute brucellosis diagnosed <0.05
Yes 18 (82%) 4 (18%)
No 5 (42%) 7 (58%)
* P-value calculated using Fisher’s Exact Test; SAT: Standard tube agglutination test.brucellosis only one (5%) relapsed five months after
treatment and none developed significant side
effects. All untreated seropositive patients
remained well, with either stable or decreasing
titers during the six months of follow-up. All symp-
tomatic and asymptomatic seronegative family
members were referred to the primary physician
for further diagnosis and follow-up.Discussion
In this study, it was found that the seroprevalence of
brucellosis in family members of acute brucellosis
cases is 19%. This is lower than has been reported in
Peru (50.9%) and more than has been reported in
Israel (9%).17,19
This variation in the seroprevalence rate among
household contacts could be attributed to the dif-
ferences in predisposing factors such as exposure to
the same risk factor and the degree of this exposure.
In a previous study a seroprevalence rate of 13% was
reported and it was demonstrated that family mem-
bers who gave a history of raw milk ingestion and
living in a large household of more than five mem-
bers were at greater risk of being seropositive.21
Such studies prove that serological screening of
family members will detect additional cases of bru-
cellosis.12,16—20,22 Due to the limitations of the SAT
tests in its ability to differentiate between acute,
chronic or past infection, diagnosis of acute brucel-
losis among family members in this study was depen-
dent on the evaluation of the clinical symptoms, a
SAT titer of >1:160 and the follow-up titers.
In this report, the evaluation of 25 index cases
uncovered 34 (19%) seropositive family members of
whom the majority, 22 (65%), had active infectionwith an acute brucellosis prevalence of 12%. This
means that for each diagnosed case, there is almost
one unidentified acute brucellosis case. The combi-
nation of clinical symptoms, serology and follow-up
of family members will therefore identify acute
brucellosis. In this study, if only the seroprevalence
rate of 19% is taken into account the number of
acute brucellosis cases would be overestimated.
Early and prompt therapy has been shown to
provide rapid recovery without complications,
despite brucellosis being known for its complica-
tions and chronicity.5,23—28 Around 10% of affected
patients have one or more systemic complication,
which is usually difficult to manage and frequently
ends in chronic disability.26,27,29 In addition, chronic
brucellosis has been reported in 10—20% of
patients.23,28
The outcome in the treated family members
reported here was excellent — all recovered rapidly
without complication and only one patient (5%)
relapsed. Therefore, the benefit of a screening
program is early detection and early treatment
resulting in fewer complications. Additionally,
family screening in Saudi Arabia is important due
to the absence of an ongoing animal disease eradi-
cation campaign.7,8 The testing and vaccination of
imported domestic animals is carried out, however,
there is no campaign to target the already infected
local domestic animals within the Kingdom which
means there is continuous exposure to infected
animals and their secretions.
This is thought to be the first study to compare
the seropositivity of symptomatic and asympto-
matic family members from families with acute
brucellosis cases. Most studies, including the
authors’ previous report, have looked into the ser-
oprevalence rate but have not evaluated the clinical
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seropositivity among symptomatic family members
was very high at 58%. This is in contrast to 8% in
asymptomatic contacts (P < 0.001). This may imply
that the cost effectiveness of screening all family
members regardless of symptoms may be question-
able, especially in developing countries with limited
resources. Screening must be considered in light of
the medical facilities available, the incidence of the
disease, the demographic characteristic of a given
population and the screening test used.
Based on the results here, it is recommended that
screening family members of an acute brucellosis
patient can be limited to the symptomatic members
only. However, it is thought that children under 14-
years of age should be screened regardless of their
symptoms. In this cohort of asymptomatic seropo-
sitives, six (55%) were children and four of them
were thought to have acute brucellosis and require
treatment upon evaluation by the infectious dis-
eases specialist. This could indicate that their symp-
toms may have been underestimated when initially
interviewed.
Human brucellosis is a multisystem disease that is
characterized by a multitude of somatic complaints,
including arthritis, arthralgia, fever, night sweats,
anorexia, fatigue, malaise and weight loss.2,3,6 In
this study it was found that fever and arthralgia are
more likely to be associated with seropositivity.
Previous studies have shown these symptoms are
the most common and prevalent symptoms in bru-
cellosis.2,3 A screening program guided by a ques-
tionnaire regarding specific symptomatology such as
fever and arthralgia is an excellent method for the
early detection of active brucellosis cases and thus
early institution of therapy with satisfactory out-
come.
In conclusion, screening the family members of
acute brucellosis cases will detect more acute infec-
tions. Symptomatic family members are more likely
to be seropositive in comparison to the asympto-
matics. Based on this, screening the familymembers
of acute brucellosis in an endemic area is strongly
recommended to enhance the detection rate, initi-
ate early treatment and reduce complications.
Where resources are limited, the screening of family
members could be limited to the symptomatic and
to children.
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